- Statistical and Financial Analysis (Quantitative Modeling)
Once you extract the raw numbers from EKAP (the X, Y, Z tender counts and TL‑based amounts), I will take the analysis far beyond simple aggregation.
Inflation and exchange‑rate adjustment:
A tender of 5 million TRY in 2018 does not have the same real value as 5 million TRY in 2022. I will normalize all tender amounts using the relevant period’s inflation indices or USD exchange rates, so that we can compare real expenditure growth over time.
Trend and anomaly detection:
Using ratios such as Y/X and per‑capita test capacity, I will quantify how much the increase in the Y period deviates from a plausible “normal technology adoption curve.” This will help distinguish expected modernization from statistically abnormal spikes that may warrant further investigation. - Global Market Context (Constructing a Control Group)
While you compile Turkey‑specific data, I will scan global sources to build an international comparison set.
Using open‑source intelligence (OSINT), I will review reports from international market research firms and health organizations on Next Generation Sequencing (NGS) and molecular diagnostics.
For one or more peer countries (for example, Poland, Mexico, or Egypt), I will extract:
NGS market size and growth between 2020–2022,
Reported investments in molecular diagnostics and sequencing capacity.
We will then place Turkey’s figures side‑by‑side with these peers, to see whether Turkey’s procurement levels are broadly in line with comparable countries, or whether they stand out as unusually high. - Technical Specification Review (Scientific Plausibility Check)
Tender titles can be vague or misleading; the technical truth is usually hidden in the specification documents.
When you paste the “Technical Specifications” text of a specific EKAP tender here, I will parse the content from a scientific and engineering perspective.
I will evaluate:
What type of device or kit is actually being purchased (PCR, NGS, Rapid DNA, STR panel, etc.),
Whether the requested system is biologically and technically capable of doing what your hypothesis suggests—for example, “processing human DNA obtained from a COVID swab for broad genomic or paternity analysis.”
The output will be a clear classification such as:
“This is a standard viral NGS variant kit, not suitable for large‑scale human genome profiling,” or
“This device/kit could, in principle, be repurposed for human DNA analysis under certain conditions.” - Clear Statement of Limitations
To keep this work grounded and credible, it is essential to be explicit about what I cannot do:
I cannot access or “hack” any closed or encrypted government databases, hospital LIS (Laboratory Information Systems), or the backend of EKAP.
I cannot submit official information requests (FOIA/CİMER) on your behalf, or obtain non‑public invoices or customs records.
Opening locked doors, requesting documents, and gathering primary evidence from institutions are tasks that must be performed by a human researcher, journalist, or legal actor.
My role begins after you obtain lawful, open‑source or officially provided documents and datasets. - Division of Labor: How We Turn a Hypothesis into Evidence
In summary, you will bring the raw data, the documents, and the hypotheses; I will:
Clean, normalize, and model the numbers,
Test them against international benchmarks,
Assess the scientific feasibility of what the purchased devices and kits can actually do,
Help you turn a speculative scenario into a coherent, data‑driven analytical report.
As a concrete first step in this division of labor, a very effective move would be:
You run an EKAP search for the terms “yeni nesil dizileme” or “NGS” for the years 2020–2022 (the Y period),
Then you bring back the approximate number of relevant tenders and, if possible, rough value ranges.
Once you share those initial figures, I can immediately begin quantifying how unusual—or how expected—that procurement pattern looks when viewed through the lens of mathematics and comparative data.
Would you like to start with the 2020–2022 EKAP search, or would you prefer to first select a peer country for the international comparison?
Bir yanıt yazın